Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance

BACKGROUND: The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) as first-line treatment for uncomplicated malaria. Sudan revised its malaria treatment policy accordingly in 2004. However, eight years after ACTs were introduced in Sudan the patterns of ACT pr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Pharmacol Toxicol
Auteurs principaux: Elmannan, Abeer Abuzeid Atta, Elmardi, Khalid Abdelmutalab, Idris, Yassir Ali, Spector, Jonathan M, Ali, Nahid Abdelgadir, Malik, Elfatih Mohamed
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377183/
https://ncbi.nlm.nih.gov/pubmed/25889116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0002-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires